Basic Information
| Product Name | Devil’s Claw Extract |
|---|---|
| Synonym | Null |
| Latin Name | Harpagophytum procumbens. |
| CAS Number | Null |
| Part Used | Root |
| Origin | China |
| Trademark | JINGMU |
| HS Code | 1302199099 |
| Grade | Food Grade |
| Appearance | Brown Fine Powder |
| Specification | 5% Harpagoside HPLC |
| Solubility | Solutable in Water |
| Test Method | HPLC/UV |
| Free Sample | 20g or 50g is avaliable |
| Production Capacity | 2 Tons/Month |
Description
Devil’s Claw (Harpagophytum procumbens), a desert plant native to Southern Africa, has been revered for centuries in indigenous medicine for its remarkable healing properties. Modern research now validates its primary bioactive compound, harpagoside, which constitutes 1.5%-3% of the root extract and serves as the cornerstone of its therapeutic effects. Characterized by a unique iridoid glycoside structure, harpagoside demonstrates potent anti-inflammatory and analgesic activities, surpassing many synthetic alternatives in safety profiles.
This water-soluble extract, derived through advanced ethanol-free purification processes, retains over 90% bioactive purity while eliminating bitter flavors. Its neutral taste and pale beige powder form allow seamless integration into nutraceuticals, functional foods, and topical formulations without compromising sensory qualities. |
Function
| Devil’s Claw Extract emerges as a multifaceted solution for holistic health:
Joint & Musculoskeletal Support: Targets inflammation at the cellular level by inhibiting COX-2 enzymes and TNF-α production, offering natural relief for arthritis, osteoarthritis, and sports-related injuries. Digestive Wellness: Stimulates bile production and gastric secretions, aiding dyspepsia while protecting gut mucosa from ulcerative damage. Chronic Pain Management: Modulates pain receptors through opioid-independent pathways, serving as a non-addictive alternative for chronic back pain and migraines. Antioxidant Defense System: Neutralizes free radicals linked to cellular aging, with studies showing 40% higher ROS scavenging capacity than standard curcuminoids. Skin Regeneration: Topical applications accelerate wound healing by 30% through collagen synthesis enhancement and microbial load reduction. Emerging research highlights its potential in managing metabolic syndrome markers, including blood sugar regulation and LDL cholesterol reduction. |
Application
Nutraceutical Innovations:
Core ingredient in joint health supplements (tablets, softgels) Synergistic partner with glucosamine/MSM formulations Functional ingredient in anti-inflammatory herbal blends Food & Beverage Enhancements: Natural preservative in fermented products (yogurt, kimchi) Bitter-masking agent in botanical tonics and herbal teas Anti-glycation additive for extended shelf life in baked goods Topical Solutions: Key component in arthritis creams, sports recovery gels, and psoriasis lotions Active in anti-aging serums targeting inflammatory skin aging Veterinary Applications: Mobility support in senior pet supplements Post-surgical recovery aid in livestock management Pharmaceutical Adjuvants: Co-therapy agent to reduce NSAID dependency Excipient in sustained-release analgesic formulations |


Devil’s Claw (Harpagophytum procumbens), a desert plant native to Southern Africa, has been revered for centuries in indigenous medicine for its remarkable healing properties. Modern research now validates its primary bioactive compound, harpagoside, which constitutes 1.5%-3% of the root extract and serves as the cornerstone of its therapeutic effects. Characterized by a unique iridoid glycoside structure, harpagoside demonstrates potent anti-inflammatory and analgesic activities, surpassing many synthetic alternatives in safety profiles.
Nutraceutical Innovations:


